Developing Antibody-Based Approaches to Reduce Downstream Allergenic Responses

Time: 2:00 pm
day: Day One


  • Re-engineering Ig-E antibodies to directly block the molecules in underlying disease
  • Potential future use of monoclonal antibody therapeutics to address specific allergies with high affinity
  • Effects of addressing key allergens directly on safety and mechanism of action